By
From the Lymphocyte Biology Section, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-1892
T cell receptor (TCR) recognition of peptide-major histocompatibility complex antigens can
elicit a diverse array of effector activities. Here we simultaneously analyze TCR engagement
and the production of multiple cytokines by individual cells in a clonal Th1 CD4+ cell population. Low concentrations of TCR ligand elicit only interferon- (IFN-
) production. Increasing ligand recruits more cells into the IFN-
+ pool, increases IFN-
produced per cell, and
also elicits IL-2, but only from cells already making IFN-
. Most cells producing only IFN-
show less TCR downmodulation than cells producing both cytokines, consistent with a requirement for more TCR signaling to elicit IL-2 than to evoke IFN-
synthesis. These studies
emphasize the hierarchical organization of TCR signaling thresholds for induction of distinct
cytokine responses, and demonstrate that this threshold phenomenon applies to individual cells.
The existence of such thresholds suggests that antigen dose may dictate not only the extent, but
also the quality of an immune response, by altering the ratios of the cytokines produced by activated T cells. The quantitative relationships in this response hierarchy change in response to
costimulation through CD28 or LFA-1, as well as the differentiation state of the lymphocyte,
explaining how variations in these parameters in the face of a fixed antigen load can qualitatively influence immune outcomes. Finally, although the IFN-
/IL-2 hierarchy is seen with
most cells, among cells with the greatest TCR downmodulation, some produce only IFN-
and not IL-2, and the amount of IFN-
exceeds that in double producers. Thus, these single
cell analyses also provide clear evidence of nonquantitative intraclonal heterogeneity in cytokine production by long-term Th1 cells, indicating additional complexity of T cell function
during immune responses.
Antigen-receptor (TCR) recognition of peptide-MHC
molecule ligands elicits a diverse array of effector activities from T cells, including secretion or surface expression of cytokines influencing cell function in an autocrine
and paracrine fashion (1, 2). The ratios of individual cytokines to one another determine whether the immune response is predominantly of the humoral or inflammatory type (3), or whether T cells proliferate, become anergic, or undergo apoptosis (4). A key issue in understanding the relationship between antigen exposure and immune response
is the relationship between antigen load and the relative
production of each mediator. Upon TCR engagement, do
T cells make all of their cytokines in a fixed proportion,
with only the absolute quantity varying with occupancy, or
does changing the level of TCR signaling affect the relative
production of each cytokine differently? Evidence for the
latter possibility could help explain why different classes of
T cell responses occur at different antigen concentrations (5, 6). Some investigators have reported the selective production of IL-4 versus IFN- Most studies on the quantitative relationship between
antigen-receptor engagement and T cell function have involved analysis of the pooled responses of cell populations
exposed to variations in ligand density in the form of antireceptor antibodies or peptide-MHC molecule ligands. Even
using cloned responding populations, this type of analysis
does not directly reveal the relationship between the extent
of TCR engagement and effector response, which might vary among the individual cells even in such putatively homogenous populations, or differences in the responses of
single cells within a cloned population based on parameters
other than TCR occupancy. Such diversity could arise due
to epistatic differences among cells in the state or number
of molecules involved in signaling or gene transcription, or
because of variation in the exposure to APCs in the cultures, which themselves may be heterogeneous in terms of
antigen display and accessory molecule function (12, 13).
Most significantly, they cannot determine whether an increasing antigen dose leads to a greater response per cell, or
to a greater number of responding cells, with production
per cell remaining relatively constant. Evidence for the latter possibility has been reported using artificial promoter
constructs expressed in transformed T cell lines (14, 15).
We were therefore especially interested in analyzing T
cell responses to peptide-MHC molecule ligands using
methods that would permit quantitation of TCR engagement on the responding T cells and at the same time allow
measurement of multiple effector responses by each of the
cells in the same antigen-exposed population. Several recent advances have made such an analysis feasible. A number of studies have shown that effective engagement of the
TCR complex leads to downmodulation of TCR expression (16), apparently through endocytic uptake that is
dependent on the activity of tyrosine kinases activated by
ligand interaction with the receptor (19, 20). In addition,
methods for intracellular staining of various cytokines permit quantitative analysis of the effector responses of individual T cells (21). Because both of these approaches depend on flow cytometric measurement, it is possible to
simultaneously evaluate TCR engagement and multiple effector responses in each cell of a population under varying
conditions.
Here we report the result of such experiments using several Th1 clones of mouse origin. Our studies reveal a hierarchical organization of TCR signal-dependent response
thresholds for elicitation of different cytokines in individual
cells. This result has significant implications for the mix of
cytokines produced at a given antigen dose level, and
hence, the quality of the ensuing immune response. The
quantitative relationships between these hierarchical thresholds can be modulated by antigen-unspecific cosignals and
by the state of differentiation of the T cell, suggesting a
mechanism by which costimulatory signals affect the polarization of immune responses (22). Our data are also consistent with earlier proposals that the amount of IL-2 produced by single cells does not vary over a large range in the
face of increasing antigen density (14, 15). Instead, the primary factor involved in the rising response of the cell population is growth in the proportion of cells making this
cytokine at a relatively fixed level. The existing evidence that this latter phenomenon relates to cooperative promoter occupancy by transcription factors suggests a general
molecular model for the regulatable hierarchical response
thresholds we document here. Finally, we note the existence of intraclonal heterogeneity in the production of cytokines characteristic of fully differentiated Th1 cells that
cannot be readily attributed to quantitative differences in
TCR signaling. This latter observation agrees with previous reports concerning the low frequency of individual cells
producing the complete set of cytokines considered prototypic of the Th1 or Th2 state (24). We suggest that this
latter form of response heterogeneity may play a special
role in the memory versus effector properties of individual
T cells.
Peptides.
Peptides were synthesized, purified, and the products
analyzed by the National Institute of Allergy and Infectious Diseases Peptide Facility. The sequences of PCC88-104 and MCC93-103(97I) are KAERADLIAYLKQATAK and DLIAILKQATK, respectively.
T Cell Clones and APCs.
A.E7 and 3C6 are Th1-cell clones
specific for pigeon cytochrome c (PCC) 88-104 and I-Ek (28).
These clones were maintained by intermittent stimulation with
B10.A spleen cells and PCC88-104 and expansion in IL-2-containing medium, followed by rest in the absence of APC, antigen,
or growth factor. All cells studied here were used no earlier than
2 wk after restimulation and cytokine expansion. Live cells were
isolated from such resting cultures using Lympholyte M (Cedarlane Labs Ltd., Hornby, Ontario, Canada). P13.9 is a supertransfected derivative of the DAP.3 fibroblast-derived transfectant
DCEK Hi7 that expresses high constitutive levels of I-Ek, CD80,
and ICAM-1. The DCEK Hi7 parent expresses similar levels of
I-Ek, but has low CD80 and little or no ICAM-1 (29).
ELISA Measurement of Functional Responses.
P13.9 were cultured with peptide overnight at 37°C, then treated with mitomycin c (20 µg/ml) at 37°C for 1 hr, and washed four times with PBS.
T cell clones (2.5 × 104/well) were cultured with APC (5 × 104/well) in 96-well flat-bottomed plates. Supernatants were collected 24 h later. ELISA assays were done using mAb JES6-1A12
and biotinylated JES6-5H4 for IL-2, MP2-8F8 and biotinylated
MP2-43D11 for IL-3, and R4-6A2 and biotinylated XMG1.2 for
IFN- Single Cell Analysis of Cytokine Production and TCR Expression.
In most experiments, P13.9 were cultured with peptide
overnight at 37°C and unbound peptide was washed away. T cell
clones (5 × 105) and APC (106) were cultured in 5 ml polypropylene tubes (FALCON 2058; Becton Dickinson, Franklin
Lakes, NJ) in the presence of monensin (2 µM; Sigma Chemical
Co.). In other experiments, T cells (2.5 × 105) with or without
precoating with anti-CD28 (2 µg/ml) were stimulated using
anti-CD3 Quantitative Reverse Transcriptase-PCR.
T cell clones (5 × 106)
were cultured with P13.9 (107) for 5 h as above. Total RNA was
extracted with RNA STAT-60 (Tel-Test "B", Inc., Friendswood, TX). cDNA was synthesized using random hexamers and
reverse transcriptase. The first PCR was performed using 1 µl of
cDNA reaction sample, Induction and Response Analysis of Anergic Cells.
P13.9 were cultured with or without peptide and Dynabeads (Dynal Inc., Oslo,
Norway) overnight. A.E7 (2 × 106) was cultured with APC (2 × 106) for 24 h in 5-ml tubes. After washing with 0.5 mM EDTA-PBS, APC were depleted with a magnet. After 7 d of rest, A.E7
was restimulated with P13.9 and 10 µM PCC88-104 for 5 h and
stained as described above.
We have shown
previously that the ligand concentration needed to elicit
50% of the maximum response by the 3C6 Th1 clone for each of two cytokines (IL-2 and IL-3) can differ by up to
100-fold, and that this relationship depends in large measure on the availability of CD28 costimulation (9). These
data were interpreted as evidence for hierarchical TCR occupancy thresholds for triggering individual effector responses. Similar findings have been made in studies using
human T cells, which show that induction of IFN-
Multiparameter flow cytometric assays for intracellular cytokine levels were conducted to examine
whether these ELISA findings reflect the properties of individual cells in a population. In accord with the lower antigen dose requirement for IFN-
One possible explanation for the asymmetries seen in the
ELISA and flow cytometric data for IL-2 and IFN-
TCR downmodulation serves as a convenient single cell measure of TCR occupancy (10, 18).
The same cell populations analyzed for cytokine production by intracellular staining were therefore also analyzed
for TCR expression before and after antigen exposure for
5 h, a time point we find to be near the plateau of TCR
downmodulation under these conditions (Itoh, Y., and
R.N. Germain, manuscript in preparation). For 3C6, both
the majority of cells producing only IFN-
These same data have also been analyzed by identifying
the cells with the 15% highest and 15% lowest TCR levels
after antigen exposure (Fig. 5 C) and examining their cytokine profiles (Fig. 5 D). The TCRlow population is greatly
enriched in cells producing both IL-2 and IFN- The above
experiments were conducted using APCs with a fixed
CD80 and ICAM-1 display. Costimulatory signals produced by CD28 interaction with CD80 or CD86 markedly
augment the total amount of IL-2 secreted at a given level
of offered TCR ligand, with a lesser effect on other cytokines such as IL-3 and IFN-
If Th1 cells
are first exposed to TCR ligand and deprived of IL-2, subsequent stimulation in the presence of CD80/86+ APC reveals a relatively selective loss of IL-2 production (proliferative anergy) (4, 12, 13). The predominant effect on IL-2
has been attributed to a specific signaling lesion affecting
IL-2 gene induction, possibly mediated through a block in
the ras-raf-ERK pathway (32, 33). Like elimination of
CD28 costimulation, this may also represent a shift in the
relative TCR occupancy thresholds for individual cytokine
responses. To explore this possibility, A.E7 cells were rendered anergic using the partial agonist peptide 97I (31),
then rested. The recovered cells were restimulated using
CD80+/ICAM-1+ APC and agonist PCC88-104 peptide.
Cells precultured with antigen-free APC show the expected IFN-
Many studies of T cell activation involve either populations rather than single cells, analysis of only one response
parameter, or assay at only one or a few antigen concentrations. The simultaneous study of multiple T cell effector
responses over a wide dose range and at the single cell level
can provide substantial additional insight into how the extent of TCR signaling relates to a T cell's functional response. Some single cell analyses involving only one or two
of these several parameters have been reported previously. Kelso et al. (26) measured multiple cytokine responses from individually cloned cells and reported on the diversity of
responses seen under putatively homogenous stimulation
conditions. Based on these data, they have argued for a stochastic pattern of effector responses, with available cytokines and cosignals in the environment determining the
relative frequency of a particular type of response but not
unequivocally inducing it. Bucy and co-workers (25, 27)
have conducted elegant double-label in situ hybridization studies of cytokine mRNA levels in bulk and cloned T cell
populations polarized to the Th1 or Th2 types. These experiments have shown a low frequency of cells producing
more than one of the prototypic cytokines of the Th1 (IL-2
or IFN- The data reported here use a multiparameter single cell
approach to investigate these and related issues. Our findings provide strong support for a model of T cell activation
in which different effector functions have a hierarchical arrangement of elicitation thresholds, such that the ratio of
elicited effector molecules changes with antigen concentration. This threshold phenomenon affects individual cells in
a clonal population and primarily determines at what level
of TCR signaling a cytokine response occurs, rather than,
or in addition to, how much of the cytokine is synthesized
by the cell. This is especially true for IL-2. These results
concerning the hierarchical organization of cytokine response thresholds provide a possible explanation for how
antigen dose controls the quality of immune responses (5,
6), based on the differing ratios of (counterregulatory) cytokines produced at distinct antigen concentrations. Another intriguing implication of the present findings is that
the lower threshold for IFN- An important and as yet unresolved issue is how the hierarchies distribute among cells in an evolving polyclonal T
cell response. Although the order for some specific responses is similar for related cells (IFN- One surprising result was that the variation in response
among a clonal T cell population extended to cells that
showed clear evidence of TCR downmodulation, and yet
failed to make any detectable cytokine, or that showed extensive TCR downmodulation and made even higher levels of IFN- In addition to the existence of a critical signaling threshold for elicitation of a particular cytokine response, as antigen concentration rises beyond this point, there is an increase in the overall amount of cytokine produced by a cell
population. There is some evidence in model systems that
this rise largely depends on the recruitment of more cells
into the responding pool, with each cell making a relatively
constant cytokine amount (digital response) (14, 15, 25). In
this study, evidence that such digital effects play a major
role in the quantitative responses of cell populations was
seen for IL-2 responses under the control of an intact endogenous regulatory region, confirming these earlier results. The IFN- The interpretation given to the sharp threshold for response in previous experiments was the cooperative nature
of transcription factor function (14). An increasing number
of reports have provided evidence that little or no gene
transcription is seen until all the proteins necessary for making a complete assembly on the promoter are available in
the cell at an adequate concentration, following which
transcription ensues at a relatively fixed level (36, 37). In
vivo footprinting studies of the IL-2 gene in particular (38)
have provided direct evidence in favor of this model of cooperative transcription factor binding for effective promoter loading and mRNA synthesis (39). This evidence for
gene activation thresholds set by the limiting nature of certain transcription factors can explain not only the discrete
cell recruitment seen as antigen dose is increased, but may
also explain the differing response thresholds for individual
effector responses and their modification by costimulation
or anergy induction. If we consider that several distinct factors are needed for optimal transcription of a given cytokine gene, it is reasonable to postulate that the response hierarchy reflects to a large extent the composite efficiency with which TCR-activated and cosignal-activated transcription factors load onto different cytokine gene promoters, based on the arrangement, number, and nucleotide
sequence of their factor binding sites (40). Those promoters most dependent for function on either factors uniquely
induced by costimulation or a specific subset of TCR signals would be most affected by modifications in these parameters. This model can explain why variation in antigen dose with constant costimulation, changing costimulation
with fixed antigen dose, or intracellular interference with
the TCR signaling pathway (anergy) in the face of fixed
TCR occupancy and costimulation can all result in the
same phenotypic response from a T cell, seen here as the
relatively selective loss of IL-2 production with maintenance of IFN- The altered downstream intracellular signaling induced
by partial agonists (43, 44) might also change the relative
extent of activation of distinct transcription factors within
the cell. This in turn will affect the relative activity of certain genes whose promoter function differs with respect to
the need for these factors. Such differences could account
for the shift of >10-fold seen for the ED50 for activation-induced cell death versus effector cytokine secretion by
A.E7 cells exposed to wild-type versus variant peptide
ligands (Combadiére, B., C. Reis e Sousa, R.N. Germain, and M.J. Lenardo, manuscript submitted for publication),
the selective loss of IL-2 in contrast to the IL-3 production
seen with antagonists of the 3C6 TCR (9), or the induction of IL-4 secretion without proliferation in a Th2 clone
by a variant ligand (45). Because of the reinforcing and
counterregulatory effects of cytokines (3) and because in the
thymus even a small change in ligand-induced signaling can
convert a deletional response to a positive selection event
(46), such changes in the relative positioning of two hierarchical responses may have major effects on the biological outcome. Thus, the quality as well as the magnitude of
an evoked immune response will be influenced by both antigen dose and the pharmacologic properties of the TCR
ligand(s) to which the antigen gives rise.
at low versus high antigen
concentrations, respectively (7, 8). We have shown that for
a mouse Th1 clone, the ligand concentration needed for
half-maximal production of each of two cytokines can differ
by 10-100-fold, due in part to the distinct effect of CD28-mediated costimulation on the two responses (9) and similar findings have been reported using human T cells (10, 11).
These limited data suggest that the effect of antigen dose on
immunity may reflect distinct TCR signaling thresholds for
individual cytokine responses that can be modified by additional signals from the APC.
(PharMingen, San Diego, CA). To detect the binding of
biotinylated antibodies, alkaline phosphatase-conjugated avidin
(Sigma Chemical Co., St. Louis, MO) was followed by p-nitrophenyl phosphate (Sigma Chemical Co.). The reaction product
was measured at 405 nm and the results converted into cytokine
units using standard curves.
immobilized in 48-well plates. After culture, cells
were washed with PBS containing 0.5 mM EDTA. Surface molecules were stained with biotinylated anti-V
3, anti-TCR C
,
or anti-CD40L antibody followed by streptavidin-CyChrome
(PharMingen). After washing with PBS, cells were fixed with
PBS containing 4% paraformaldehyde for 5 min at 37°C, then
washed with PBS (1% BSA) once. After two additional washes
with PBS (0.1% saponin, 0.1% BSA, and 0.01 M Hepes), FITC-
anti IFN-
and PE-anti IL-2 antibodies (PharMingen) were
added (21). Before flow cytometry acquisition, stained cells were
washed twice with PBS (0.1% saponin, 0.1% BSA, and 0.01 M
Hepes). T cells were gated using FSC/SSC parameters and 2 × 104
cells were analyzed.
-actin primers (0.4 µM), Taq DNA
polymerase (2.5 U, Perkin Elmer, Norwalk, CT), dNTP (200 µM), [32P]dCTP (1 µCi; Amersham Corp., Arlington Heights,
IL), and MgCl2 (2.5 mM) in a total volume 50 µl. The reaction
was 25 cycles of denaturation 94°C for 1 min, annealing 55°C for
1 min, and extension 72°C for 2 min. After electrophoresis in 8%
polyacrylamide gels and autoradiography, densitometric analysis
was performed. Based on these data, the volumes of cDNA solutions containing the same amount of
-actin templates were calculated. After a second PCR was done in order to confirm that
the adjusted cDNA amounts give the same level of amplification
of
-actin among samples, specific primers for
-actin, IL-2, or
IFN-
were used in a third PCR. Incorporated radioactivity in
bands of appropriate size was quantified by densitometer analysis
of the autoradiographs. Results of these experiments are presented as the percentage of the maximum response of the cells
to antigen. The primer sequences used were:
-actin sense
5
-GTGGGCCGCTCTAGGCACCAA-3
and antisense 5
-CTCTTTGATGTCACGCACGATTTC-3
; IL-2 sense 5
-ATGTACAGCATGCAGCTCGCATC-3
and antisense 5
-GGCTTGTTGAGATGATGCTTTGACA-3
; and IFN-
sense 5
-TGAACGCTACACACTGCATCTTGG-3
and antisense 5
-CGACTCCTTTTCCGCTTCCTGAG-3
.
Hierarchical Arrangement of Antigen Dose Thresholds for Distinct Cytokine Responses of CD4+ Th1 Cells.
production and proliferation require substantially more antigen-induced TCR downmodulation than cytotoxicity (10).
To expand on these previous observations, ELISA was used
to measure cytokine secretion in response to agonist peptide-MHC class II ligand presented by transfected cells
whose CD80/CD86-mediated costimulatory function does
not change in response to T cell signals. Fig. 1 shows
IFN-
, IL-2, and IL-3 production by two different Th1
clonal cell populations (3C6 and A.E7), displayed as percentage of maximum response to allow direct comparison
of the fractional response for each mediator at each antigen
concentration. The ligand amounts eliciting the minimally
measurable and maximal responses are different for each cytokine, with the overall hierarchy being IFN-
> IL-2 > IL-3 for 3C6 and IFN-
> IL-3 = IL-2 for A.E7. These
findings confirm earlier data suggesting that the numbers of
TCR ligands needed to elicit a fixed fractional response for
different cytokines are distinct. They also demonstrate that
among individual clones, some effector responses (IL-3 in
this case) may vary in their relative position in this dose-
response hierarchy.
Fig. 1.
Hierarchical cytokine production thresholds detected by
ELISA. 3C6 and A.E7 were cultured with P13.9 and PCC88-104. Supernatants were collected 24 h later and IL-2, IL-3, and IFN- secretion was
determined by ELISA. The results were converted into cytokine units using standard curves and expressed as the percentage of the maximum response obtained for each cytokine at plateau. Absolute cytokine production representing the maximal response on this scale ranged in various
experiments from 50 to 200 U/ml for IL-2, 6,000 to 19,000 U/ml for
IFN-
for both cells, 5 to 25 U/ml for 3C6, and 80 to 700 /ml for A.E7
for IL-3.
[View Larger Version of this Image (16K GIF file)]
production seen by
ELISA, staining of activated A.E7 for IFN-
and IL-2 after low level (0.1 nM) antigen exposure reveals only two populations, IFN-
single producers and cells making neither
IFN-
nor IL-2 at detectable levels (Fig. 2). As the antigen
concentration is increased, cells producing IL-2 become
apparent, but these IL-2 producers also make IFN-
. Both
the number of cells making IFN-
and the amount of this
cytokine per cell increase with antigen concentration. In
contrast, IL-2 production remains more constant per cell as
ligand increases, with the primary change being in the
number of cells making this cytokine at a fixed level. 3C6 shows a similar pattern as antigen dose is increased, although somewhat more cells making IL-2 with low accompanying IFN-
production are observed at a high antigen
concentration (Fig. 2). These single cell data thus confirm
the results of the ELISA, showing that IFN-
is made by
the cells at lower offered antigen doses than those required
for IL-2. They further show that this hierarchical relationship reflects the behavior of individual cells in the population, each of which makes either IFN-
or both IFN-
and IL-2, but not IL-2 alone. Each cell thus shows a higher
response threshold for IL-2 production, rather than there
being two different sets of cells in the population each
making either IL-2 or IFN-
, and each with distinct sensitivities to TCR signals. In contrast to this relationship for
IL-2 and IFN-
, a similar analysis examining single cell
IFN-
and CD40L responses shows a different result (Fig.
3). Virtually no cells make only one or the other cytokine, and only a small fraction of cells makes responses strongly
biased to one or the other mediator. Instead, the majority
of cells make similar levels of both cytokines, indicating
that for these two responses, the triggering thresholds are
similar.
Fig. 2.
Cytokine production analyzed at the single cell level. Intracellular IFN- and IL-2 were determined by flow cytometry after 5 h of culture
in monensin with the indicated concentration of PCC88-104 and P13.9 APC. The numbers in each figure refer to the percentage of the total cell number and the FL1 (IFN-
) and FL2 (IL-2) mean intensities of cells in the indicated quadrant of the two-parameter histograms.
[View Larger Version of this Image (40K GIF file)]
Fig. 3.
Similar stimulation thresholds for IFN- and CD40L production. 3C6 cells were stimulated for 8 h with P13.9 APC alone (left) or
with P13.9 pulsed with 10 µM PCC88-104 (right) in the absence of monensin, then stained surface CD40L expression and intracellular IFN-
content.
[View Larger Version of this Image (27K GIF file)]
versus
the lack of such asymmetry for IFN-
and CD40L is in the
characteristics of the antibodies used in the assays. It was
possible that the anti-IFN-
antibodies are more sensitive
detectors of their ligand than the anti-IL-2 antibodies, but
comparable to anti-CD40L in this regard. To address this
issue, reverse transcriptase-PCR assays were run using
mRNA from cells treated similarly to those used for the
experiments shown in Figs. 1 and 2. This provides an antibody-independent approach to analysis of cytokine responses, although not on a single cell basis. The data confirm the results of the two assays using antibody detection
of product, in that the IFN-
response is first detected at a
10-30-fold lower antigen concentration than is the IL-2
response (Fig. 4).
Fig. 4.
Reverse transcriptase-PCR analysis of T cell cytokine responses. IFN- and IL-2 mRNA levels were analyzed for 3C6 and A.E7 after stimulation with P13.9 APC pulsed with varying PCC88-104 concentrations.
[View Larger Version of this Image (17K GIF file)]
and many of
the IFN-
-negative cells have a similar TCR level, lower
than that on cells not exposed to specific antigen (Fig. 5 B).
These data indicate that a subpopulation of these cloned T
cells engage their TCR, but fail to make either of the studied cytokines. In contrast, the TCR expression of IL-2-
producing cells is lower than that of IL-2-negative cells
(Fig. 5 B), suggesting that the former have undergone more
TCR downmodulation, and have therefore received more
antigen-dependent signals.
Fig. 5.
TCR downmodulation and cytokine production. T cell clone 3C6 was cultured with P13.9 + PCC88-104 (10 µM) in the presence of monensin. After 5 h of incubation, surface TCR V3, as well as intracellular IFN-
and IL-2, were analyzed. (A) IFN-
and IL-2 production by 3C6.
R1 = cells producing both IFN-
and IL-2; R2 = cells producing IFN-
alone; R3 = cells producing neither IFN-
nor IL-2. (B) TCR expression of
each cell subpopulation after incubation with 10 µM PCC88-104 + P13.9. Gates R1, R2, and R3 are as in A. The histogram for cells in R2 largely
overlaps that for cells in R3. (C) Ungated TCR expression of 3C6 incubated with either with 10 µM PCC88-104 (solid line) or without peptide (dotted line) + P13.9. The gates set to analyze cytokine expression by the cells with the 15% lowest (TCRlow) and 15% highest (TCRhi) receptor levels after incubation are indicated. (D) IFN-
and IL-2 production profiles of TCRlow and TCRhi populations as detailed in C. The percentage of total cells and the
mean intensity of cytokine staining are shown for cells in the respective quadrants of the two-parameter histograms.
[View Larger Version of this Image (21K GIF file)]
as compared with the TCRhi population. This population also
contains the very small number of cells making substantial
IL-2 and a low level of IFN-
as well as those producing
the greatest amount of IFN-
alone. In contrast, many of
the TCRhi cells produce high amounts of IFN-
without
IL-2. These results demonstrate at the individual cell level
that IL-2 production requires more TCR triggering (has a
higher signaling threshold) than IFN-
production, indicating that the response hierarchies seen when varying offered antigen concentration reflect the requirement at the
single cell level for different amounts of TCR-derived signals for the production of each cytokine. These observations also indicate that for some cells, the failure to make
IL-2 is not the result of TCR engagement inadequate to
reach the quantitative signaling threshold for production of
this cytokine. These cells produce a greater amount of
IFN-
than cells making both IFN-
and IL-2 and they
have undergone similar, extensive TCR downmodulation as the double producers, suggesting an intraclonal heterogeneity in response potential distinct from the quantitative
hierarchy seen in other cells for IFN-
versus IL-2 production.
and
IL-2 Production by Variation of Costimulatory Signals.
(4, 12, 13). The quantitative
aspects of the hierarchical relationships just described might
thus be modified by changing the costimulatory environment in which the T cell is signaled, an idea for which some support already exists (9, 11, 24, 25, 30). DCEK Hi7
is a transfected APC that has the same I-Ek levels as P13.9,
but expresses low CD80 and little or no ICAM-1 (29, 31).
At 10 µM peptide, DCEK induces a similar fraction of the
cells to produce IFN-
as does P13.9 (Fig. 6 B), although the amount of IFN-
per cell is somewhat lower than with
the CD80+ cells. However, the difference between P13.9
and DCEK is most remarkable looking at IL-2 production.
P13.9 and 10 µM of PCC88-104 induce numerous IL-2-
positive cells, whereas DCEK + PCC88-104 stimulate
only very few IL-2-producing cells at the same antigen dose, despite promoting the same level of TCR downmodulation (Fig. 6, B and C). These data directly demonstrate that CD28- and ICAM-1-mediated costimulation
can change the relative TCR occupancy thresholds required for elicitation of different cytokines. This effect on the functional response to TCR signaling occurs without
substantially altering the extent of TCR engagement, indicating an intracellular site of action rather than a change in
the efficiency of ligand recognition. Fig. 6 also shows that
the change in threshold upon removal of CD28 costimulation reveals itself not in a grossly different amount of IL-2
produced per cell, but in a smaller number of cells producing IL-2 at all. A similar result is obtained if the peptide
ligand is replaced by anti-CD3 and CD80 signaling replaced by anti-CD28 antibody, to reduce the possibility
that variations in cell-cell contact contribute to these findings (Fig. 7). Thus, the threshold change appears to affect
the cells individually in an all-or-none fashion, as also observed when examining the antigen-dose response in the
presence of fixed costimulation (Fig. 2).
Fig. 6.
Effect of costimulation on signaling thresholds for effector responses. A.E7 was cultured with P13.9 (costimulationhi) or DCEK Hi 7 (costimulationlo) APC plus 10 µM PCC88-104 for 5 h in the presence of monensin, then stained as described in Fig. 2. The left and middle figures show IFN-
and IL-2 production stimulated by P13.9 and DCEK Hi 7, respectively. The right histogram shows TCR expression after stimulation.
[View Larger Version of this Image (23K GIF file)]
Fig. 7.
Effect of CD28 costimulation on response threshold, the number of responding cells, and the response per cell for IL-2 and IFN- induced
by anti-CD3 antibody. A.E7 cells were precultured without (top) or with (bottom) anti-CD28 antibody and then added for 5 h to the wells of plates precoated with the indicated concentration of anti-CD3 antibody. The cells were then stained for intracellular IL-2 and IFN-
.
[View Larger Version of this Image (36K GIF file)]
only and IFN-
+ IL-2 double-producing populations upon restimulation (Fig. 8 A). In contrast, T
cells precultured with APC bearing 97I show very few cells
producing IL-2, and the population of high IFN-
only
producers requiring extensive TCR engagement under
normal conditions is also diminished (Fig. 8, B and C).
Cells from both treatment groups have the same TCR levels at the beginning and end of the assay culture (Fig. 8 D),
indicating that there is no defect in occupancy-induced downmodulation in the 97I-exposed (anergic) cells. Thus,
the cytokine response of Th1 cells rendered anergic resembles that of cells exposed to low levels of antigen or deprived of CD28 costimulation (compare Figs. 2, 6, 7, and 8 B).
Fig. 8.
Cytokine production by anergized T cells. A.E7 was cultured with P13.9 alone (A) or P13.9 with 50 µM MCC97I (B) for 24 h. After separation from APC and resting for a week, cells were restimulated with P13.9 and 10 µM PCC88-104 in the presence of monensin, then stained with
anti-IFN-, IL-2, and TCR antibodies. IFN-
production and TCR expression are shown after the second incubation in C and D, respectively. Cells
precultured with P13.9 and MCC97I (
) or P13.9 without peptide (----) were restimulated with P13.9 and PCC88-104. Cells without antigen restimulation were shown (·····) for both cell populations.
[View Larger Version of this Image (25K GIF file)]
) or Th2 (IL-4, IL-5, or IL-10) phenotype. These
data suggest intraclonal heterogeneity of response, but because the extent of signaling in the cells could not be coanalyzed, quantitative versus qualitative explanations for these findings could not be distinguished. Lanzavecchia and co-workers (11, 18) have introduced flow cytometric measurement of TCR levels as a single cell measure of TCR
signal intensity. Using this method together with functional
analysis on a population basis, they have concluded that hierarchical thresholds of the type reported for mouse Th1
cytokine responses (9) are seen for human T cells and, like
the mouse hierarchy, can be influenced by costimulatory
signals. However, neither these latter studies nor our own
previous work determined whether cell-to-cell heterogeneity and statistical bias in response of the type described by
Kelso et al. or a common and consistent hierarchy seen in
each cell in the population accounted for the relationship
between antigen dose and induction of distinct responses.
production by Th1 cells
may allow them to amplify their responses by induction of
antigen processing and presentation-related genes (DM,
MHC class II) (34, 35) which in turn help provide the additional ligand needed to elicit IL-2 production and clonal expansion.
versus IL-2 in our
Th1 clones), there are clear variations among different
clones in the relative positioning of other responses (IL-3 in
this case). This heterogeneity in relative threshold positioning could account for the data of Kelso et al. (26), in which
at a single antigen dose, different T cells in a nonclonal
population produce a varying mix of cytokines that do not
follow a clear Th1 or Th2 pattern. The extent to which such variation will influence the effect of response threshold hierarchy on the quality of in vivo immune responses is
not yet known. The range of TCR affinities in heterogeneous responding T cell populations, combined with hierarchical cytokine thresholds in each cell, might account for
data suggesting that entirely different cytokines are specifically elicited at low and high antigen concentrations (7, 8).
Finally, CD80 and CD86 have been reported to have a different potential to promote T cell differentiation towards a
Th1 or Th2 phenotype (22, 23), while ICAM-1 has been
found to increase both the number of responding T cells in
a population and their production of IFN-
(24). Here we
have shown that the relative production of IL-2 versus IFN-
changes in the presence versus the absence of
ICAM-1 and CD80-dependent signaling under the same
conditions of TCR engagement. It seems plausible that
similar shifts in the relative elicitation of IFN-
versus IL-4
in Th0 cells (rather than the IL-2 studied here using long-term Th1 clones) could account for the predilection of one
or the other cosignal to favor a particular response polarization.
than cells producing both cytokines without
detectable IL-2. We have isolated the cells that make neither IL-2 nor IFN-
but show extensive TCR engagement
by sorting for CD40L-negative cells generated in the absence of monensin. Upon reculture, some of these cells regain the ability to respond to antigen by producing cytokine, suggesting that after prolonged rest a fraction of the T
cells in these clones is in a reversible state of reduced responsiveness to TCR engagement. Preliminary data indicate that this may correlate with the level and/or function of src kinases in these T cells (Itoh, Y., I. Stefanova, and
R.N. Germain, unpublished observations). The cells producing IFN-
without IL-2 are perhaps an even more intriguing intraclonal population. If this IL-2 nonproducer
state is not a readily reversible one, they would be excellent
candidates for "terminally differentiated effectors" lacking
the capacity for extensive self-renewal, whereas the double
producers would be able to respond to additional antigen exposure with clonal expansion. This possible segregation
of clonal progeny into proliferating memory cells versus
high-rate secreting effectors is reminiscent of the distinction between renewing memory B cells and fully differentiated plasma cells. This raises the intriguing possibility that
selective loss of proliferative responses to TCR signaling in
the face of costimulation, a state akin to classical clonal anergy (4), might be a regular part of the immune response,
permitting delivery of potent effector function without
overexpansion of a potentially dangerous T cell pool.
response was more complex, with what
appears to be up to a fourfold increase in intracellular cytokine levels as antigen concentration rises above the threshold level, as well as the recruitment of more cells into the
responding pool over the same dose range. This contrasts
with the report of similar amounts of IFN-
mRNA detected by in situ hybridization in individual cells activated
at both high and low dose of antigen (25).
generation.
Address correspondence to Dr. Ronald N. Germain, Lymphocyte Biology Section, Laboratory of Immunology, National Insitute of Allergy and Infectious Diseases, National Institutes of Health, Building 10, Room 11N311, 10 Center Drive, MSC-1892, Bethesda, MD 208092-1892. Phone: 301-496-1904; FAX: 301-496-0222; E-Mail: Ronald_Germain{at}nih.gov
Received for publication 22 May 1997 and in revised form 1 July 1997.
The authors wish to thank all the members of the Lymphocyte Biology Section for helpful discussion and B. Hemmer, R. Martin, I. Stefanova, L. Nicholson, M. Collins, and V. Kuchroo for sharing data before publication.
1. | Paul, W.E., and R.A. Seder. 1994. Lymphocyte responses and cytokines. Cell. 76: 241-251 [Medline]. |
2. | Janeway, C.A. Jr., and K. Bottomly. 1994. Signals and signs for lymphocyte responses. Cell. 76: 275-285 [Medline]. |
3. | Seder, R.A., and W.E. Paul. 1994. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu. Rev. Immunol. 12: 635-673 [Medline]. |
4. | Schwartz, R.H.. 1996. Models of T cell anergy: is there a common molecular mechanism? J. Exp. Med. 184: 1-8 [Medline]. |
5. | Parish, C.R.. 1971. Immune response to chemically modified flagellin. II. Evidence for a fundamental relationship between humoral and cell-mediated immunity. J. Exp. Med. 134: 21-47 [Medline]. |
6. | Bretscher, P.A., G.J. Wei, J.N. Menon, and H. Bielefeldt-Ohmann. 1992. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science (Wash. DC). 257: 539-542 [Medline]. |
7. |
Hosken, N.A.,
K. Shibuya,
A.W. Heath,
K.M. Murphy, and
A. O'Garra.
1995.
The effect of antigen dose on CD4+ T
helper cell phenotype development in a T cell receptor-![]() ![]() |
8. | Constant, S., C. Pfeiffer, A. Woodard, T. Pasqualini, and K. Bottomly. 1995. Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells. J. Exp. Med. 182: 1591-1596 [Abstract]. |
9. | Racioppi, L., F. Ronchese, L.A. Matis, and R.N. Germain. 1993. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor- dependent intracellular signaling. J. Exp. Med. 177: 1047-1060 [Abstract]. |
10. | Valitutti, S., S. Müller, M. Dessing, and A. Lanzavecchia. 1996. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J. Exp. Med. 183: 1917-1921 [Abstract]. |
11. | Viola, A., and A. Lanzavecchia. 1996. T cell activation determined by T cell receptor number and tunable threshold. Science (Wash. DC). 273: 104-106 [Abstract]. |
12. | Schwartz, R.H.. 1992. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell. 71: 1065-1068 [Medline]. |
13. | Linsley, P.S., and J.A. Ledbetter. 1993. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11: 191-212 [Medline]. |
14. | Fiering, S., J.P. Northrop, G.P. Nolan, P.S. Mattila, G.R. Crabtree, and L.A. Herzenberg. 1990. Single cell assay of a transcription factor reveals a threshold in transcription activated by signals emanating from the T cell antigen receptor. Genes Dev. 4: 1823-1834 [Abstract]. |
15. | Karttunen, J., and N. Shastri. 1991. Measurement of ligand-induced activation in single viable T cells using the lacZ reporter gene. Proc. Natl. Acad. Sci. USA. 88: 3972-3976 [Abstract]. |
16. | Reinherz, E.L., S. Meuer, K.A. Fitzgerald, R.E. Hussey, H. Levine, and S.F. Schlossman. 1982. Antigen recognition by human T lymphocytes is linked to surface expression of the T3 molecular complex. Cell. 30: 735-743 [Medline]. |
17. |
Saito, T.,
A. Weiss,
J. Miller,
M.A. Norcross, and
R.N. Germain.
1987.
Specific antigen Ia activation of transfected human T cells expressing murine Ti ![]() ![]() |
18. | Valitutti, S., S. Müller, E. Cella, E. Padovan, and A. Lanzavecchia. 1995. Serial triggering of many T cell receptors by a few peptide-MHC complexes. Nature (Lond.). 375: 148-151 [Medline]. |
19. |
Boyer, C.,
N. Auphan,
J. Gabert,
D. Blanc,
B. Malissen, and
A.M. Schmitt-Verhulst.
1989.
Comparison of phosphorylation and internalization of the antigen receptor/CD3 complex, CD8, and class I MHC-encoded proteins on T cells.
Role of intracytoplasmic domains analyzed with hybrid
CD8/class I molecules.
J. Immunol.
143:
1905-1914
|
20. |
Luton, F.,
M. Buferne,
J. Davoust,
A.M. Schmitt-Verhulst, and
C. Boyer.
1994.
Evidence for protein tyrosine kinase involvement in ligand-induced TCR/CD3 internalization and
surface redistribution.
J. Immunol.
153:
63-72
|
21. | Lee, C.L.Y., S.H.S. Lee, F.T. Jay, and K.R. Rozee. 1990. Immunobiological study of interferon-gamma-producing cells after staphylococcal enterotoxin B stimulation. Immunology. 70: 94-99 [Medline]. |
22. | Kuchroo, V.K., M. Prabhu, Das, J.A. Brown, A.M. Ranger, S.S. Zamvil, R.A. Sobel, H.L. Weiner, N. Nabavi, and L.H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell. 80: 707-718 [Medline]. |
23. | Freeman, G.J., V.A. Boussiotis, A. Anumanthan, G.M. Bernstein, X.Y. Ke, P.D. Rennert, G.S. Gray, J.G. Gribben, and L.M. Nadler. 1995. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity. 2: 523-532 [Medline]. |
24. |
Maraskovsky, E.,
A.B. Troutt, and
A. Kelso.
1992.
Co-engagement of CD3 with LFA-1 or ICAM-1 adhesion molecules the frequency of activation of single murine CD4+ and
CD8+ T cells and induces synthesis of IL-3 and IFN-![]() |
25. | Bucy, R.P., A. Panoskaltsis-Mortari, G.Q. Huang, J. Li, L. Karr, M. Ross, J.H. Russell, K.M. Murphy, and C.T. Weaver. 1994. Heterogeneity of single cell cytokine gene expression in clonal T cell populations. J. Exp. Med. 180: 1251-1262 [Abstract]. |
26. | Kelso, A., P. Groves, A.B. Troutt, and K. Francis. 1995. Evidence for the stochastic acquisition of cytokine profile by CD4+ T cells activated in a T helper type 2-like response in vivo. Eur. J. Immunol. 25: 1168-1175 [Medline]. |
27. | Bucy, R.P., L. Karr, G.Q. Huang, J. Li, D. Carter, K. Honjo, J.A. Lemons, K.M. Murphy, and C.T. Weaver. 1995. Single cell analysis of cytokine gene coexpression during CD4+ T cell phenotype development. Proc. Natl. Acad. Sci. USA. 92: 7565-7569 [Abstract]. |
28. |
Hecht, T.T.,
D.L. Longo, and
L.A. Matis.
1983.
The relationship between immune interferon production and proliferation in antigen-specific, MHC-restricted T cell lines and
clones.
J. Immunol.
131:
1049-1055
|
29. |
Ding, L.,
P.S. Linsley,
L.-Y. Huang,
R.N. Germain, and
E.M. Shevach.
1993.
IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7
expression.
J. Immunol.
151:
1224-1234
|
30. | Muraille, E., G. De Becker, M. Bakkus, K. Thielemans, J. Urbain, M. Moser, and O. Leo. 1995. Co-stimulation lowers the threshold for activation of naive T cells by bacterial superantigens. Int. Immunol. 7: 295-304 [Abstract]. |
31. |
Madrenas, J.,
R.H. Schwartz, and
R.N. Germain.
1996.
Interleukin 2 production, not the pattern of early T cell antigen
receptor-dependent tyrosine phosphorylation, controls anergy induction by both agonists and partial agonists.
Proc.
Natl. Acad. Sci. USA.
93:
9736-9741
|
32. | Li, W., C.D. Whaley, A. Mondino, and D.L. Mueller. 1996. Blocked signal transduction to the ERK and JNK protein kinases in anergic CD4+ T cells. Science (Wash. DC). 271: 1272-1276 [Abstract]. |
33. | Fields, P.E., T.F. Gajewski, and F.W. Fitch. 1996. Blocked Ras activation in anergic CD4+ T cells. Science (Wash. DC). 271: 1276-1278 [Abstract]. |
34. | Glimcher, L.H., and C.J. Kara. 1992. Sequences and factors: a guide to MHC class-II transcription. Annu. Rev. Immunol. 10: 13-49 [Medline]. |
35. | Chang, C.-H., and R.A. Flavell. 1995. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med. 181: 765-767 [Abstract]. |
36. | Jiang, J., and M. Levine. 1993. Binding affinities and cooperative interactions with bHLH activators delimit threshold responses to the dorsal gradient morphogen. Cell. 72: 741-752 [Medline]. |
37. | Chung, J.D., G. Stephanopoulos, K. Ireton, and A.D. Grossman. 1994. Gene expression in single cells of Bacillus subtilis: evidence that a threshold mechanism controls the initiation of sporulation. J. Bacteriol. 176: 1977-1984 [Abstract]. |
38. | Garrity, P.A., D. Chen, E.V. Rothenberg, and B.J. Wold. 1994. Interleukin-2 transcription is regulated in vivo at the level of coordinated binding of both constitutive and regulated factors. Mol. Cell. Biol. 14: 2159-2169 [Abstract]. |
39. | Chen, D., and E.V. Rothenberg. 1994. Interleukin 2 transcription factors as molecular target of cAMP inhibition: delayed inhibition kinetics and combinational transcription roles. J. Exp. Med. 179: 931-942 [Abstract]. |
40. | Tanaka, N., and T. Taniguchi. 1992. Cytokine gene regulation: regulatory cis-elements and DNA binding factors involved in the interferon system. Adv. Immunol. 52: 263-281 [Medline]. |
41. | Howard, M.C., A. Miyajima, and R. Coffman. 1993. T cell- derived cytokines and their receptors. In Fundamental Immunology. W.E. Paul, editor. Raven Press, New York. 763- 800. |
42. | Rao, A.. 1994. NF-ATp: a transcription factor required for the co-ordinate induction of several cytokine genes. Immunol. Today. 15: 274-281 [Medline]. |
43. |
Sloan-Lancaster, J.,
A.S. Shaw,
J.B. Rothbard, and
P.M. Allen.
1994.
Partial T cell signaling: altered phospho-![]() |
44. |
Madrenas, J.,
R.L. Wange,
J.L. Wang,
N. Isakov,
L.E. Samelson, and
R.N. Germain.
1995.
![]() |
45. | Evavold, B.D., and P.M. Allen. 1991. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science (Wash. DC). 252: 1308-1310 [Medline]. |
46. | Hogquist, K.A., S.C. Jameson, W.R. Heath, J.L. Howard, M.J. Bevan, and F.R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell. 76: 17-27 [Medline]. |
47. | Jameson, S.C., K.A. Hogquist, and M.J. Bevan. 1994. Specificity and flexibility in thymic selection. Nature (Lond.). 369: 750-752 [Medline]. |
48. | Hogquist, K.A., S.C. Jameson, and M.J. Bevan. 1995. Strong agonist ligands for the T cell receptor do not mediate positive selection of functional CD8+ T cells. Immunity. 3: 79-86 [Medline]. |